Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125305911 | 12530591 | 1 | I | 0 | 20160705 | 20160705 | DIR | 62.00 | YR | F | N | 158.00000 | LBS | 20160701 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125305911 | 12530591 | 1 | PS | RECLAST | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | Y | D | 0 | |||||||||
| 125305911 | 12530591 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 125305911 | 12530591 | 5 | C | GENERAL VITAMIN | 2 | 0 | |||||||||||||
| 125305911 | 12530591 | 7 | C | CALCIUM-MAGNESIUM | CALCIUMMAGNESIUM | 1 | 0 | ||||||||||||
| 125305911 | 12530591 | 9 | C | ZINC | ZINCINC CHLORIDE | 1 | 0 | ||||||||||||
| 125305911 | 12530591 | 11 | C | VITAMIN B | VITAMIN B | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125305911 | 12530591 | 1 | Osteoporosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125305911 | 12530591 | Arthralgia | |
| 125305911 | 12530591 | Blood pressure increased | |
| 125305911 | 12530591 | Myalgia | |
| 125305911 | 12530591 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |